Terlipressin-Linked Trial NCT02473341 Now Active, Not Recruiting

On July 21, 2026, a trial update was recorded for the study titled "Efficacy Of Bovine Colostrum In The Treatment Of Severe Alcohol-Associated Hepatitis: A Randomized Controlled Trial," registered as NCT02473341. This is a Phase 3 clinical trial. The trial's status is listed as active, not recruiting, as of this update date. Terlipressin is the compound referenced in connection with this trial record. No results have been reported in this update, and no efficacy or safety conclusions can be drawn from the status change alone. The update reflects only the trial's current recruitment and progress status, not any outcome data. Readers should note that a trial being active but not recruiting means enrollment has closed, but participant follow up or data analysis phases may still be ongoing. Further updates would be needed to determine when results become available. This entry is based solely on the registered trial record and its listed status as of the date provided. For more background on terlipressin, its approved uses, and regulatory status, readers can consult the compound overview.